ABSTRACT Thirty six patients previously treated for pulmonary tuberculosis by thoracoplasty were studied to determine the prevalence and effect of airflow obstruction. The mean (SD) FEV, was 1-3 (0 65) 1 and the mean forced expiratory ratio (FER) 64% (12%). FEV, was less than predicted in every patient whereas FER was less than predicted in 30, being below the lower 98th percentile in 15 (42%). In the 18 patients who complained of breathlessness the means of the standardised residuals (SR) for FEVy, peak expiratory flow (PEF), and FER were significantly lower and that for residual volume/total lung capacity (RV/TLC) significantly higher than those for the 18 patients who were not breathless (all p < 0-0001). There was no difference in the smoking history of the two groups. Only three of the 23 patients in whom reversibility of airflow obstruction was assessed showed a greater than 25% increase in PEF. None showed an increase in FEV, of greater than 15%. The 18 who were breathless had significantly lower values of arterial oxygen tension (Pao2) and higher values of arterial carbon dioxide tension (PaCo2) (p < 0-0001). Thirteen of these patients were in chronic respiratory failure (Pao2 < 8-0 kPa or PaCO2 > 5-9 kPa, or both) compared with only one of the 18 who were not breathless. The indices correlating best with Pao2 and Paco2 were SR FEV, and SR PEF respectively. SR FEV, accounted for 34% of the variance in Pao2 and SR PEF for 29% of the variance in PaCO2. Airflow obstruction has been found to be common in patients with a thoracoplasty and to be associated with hypoxia and hypercapnia.
Many patients who were treated for pulmonary tuberculosis by thoracoplasty in the prechemotherapy era are now breathless.' Some of them develop respiratory failure2 or cor pulmonale.3 These complications may even occur in patients with a thoracoplasty who were not previously breathless and who were leading apparently normal lives. 4 The reasons why some patients are affected while others remain well have not been elucidated. A restrictive ventilatory defect is inevitable after thoracoplasty5 6 and there is some evidence that hypercapnia is related to decreased inspiratory muscle strength. 7 Because several studies from the prechemotherapy era suggested that airflow obstruction was common in patients with pulmonary tuberculosis,8'-1 we studied a group of patients treated for tuberculosis by thoracoplasty to determine the prevalence of airflow obstruction, its possible mechanisms, and its clinical importance in determining breathlessness and respiratory failure in these patients.
Subjects and methods
We studied 36 patients who had previously been treated for pulmonary tuberculosis by thoracoplasty. They were divided into two groups. The first group of 18 (10 men, 8 women) had sought medical attention in recent years because of breathlessness. Seven were known to have suffered episodes of hypercapnic respiratory failure. The other group of 18 (13 men, 5 women) attended a chest clinic for follow up of their pulmonary tuberculosis. On direct questioning none of these admitted to breathlessness. Two of the' breathless patients and one of the others were shown to be atopic by skinprick testing with common allergens.
Forced expiratory volume in one second (FEVy) and forced vital capacity (FVC) were measured with a Vitalograph spirometer and peak expiratory flow (PEF) using a Wright mini peak flow meter. In 12 of the breathless patients and 11 of the others all three measurements were repeated 10 among the breathless patients were not significantly different from those observed in the patients who were not breathless. The breathless patients showed significantly lower values of Pao2 and higher values of Paco2. Thirteen (72%) of them were in respiratory failure compared with one of those who were not breathless.
Comparison of the smoking habits of the groups did not reveal any differences in lifetime cigarette consumption in pack years or duration of cigarette smoking, or in the numbers who had never smoked. The mean (SD) SR FER for the 10 who had never smoked was -186 (1[81), which was not significantly different from that of the 26 smokers, -174 (1 85).
The rank correlations between the SRs for each index of lung function and Pao2 and Paco2 are shown in table 3. On the basis of multiple linear regression and a stepwise inclusion procedure, the only predictors for Pao2 and Paco2 were SR FEV1 and SR PEF respectively. There was a positive correlation between Pao2 and SR FEV1 and a negative correlation between Paco2 and SR PEF. None of the other variables had a significant regression coefficient after 351 was there any difference in airflow obstruction between smokers and those who had never smoked. Coexisting asthma will also worsen airflow obstruction but there are no studies of the prevalence of asthma among patients treated by thoracoplasty. In our study appreciable reversible airflow obstruction was uncommon, although in 13% of those in whom it was assessed PEF increased by more than 25% after inhalation of bronchodilator.
In our patients SR FEV, was the best predictor of Pao2 and SR PEF was the best predictor of Paco2. In the only previous study of patients treated by thoracoplasty'6 Huang and Lyons found that respiratory failure best related to a low FVC and that FEV, and PEF were not important. Their patients, however, had all been treated by thoracoplasty as a procedure supplementary to pneumonectomy, so they are not strictly comparable with our patients, none of whom had had a pneumonectomy.
The pathophysiology of respiratory failure in patients with a thoracoplasty should provide an explanation for the observation that these patients frequently deteriorate suddenly, sometimes without apparent reason, having previously led seemingly normal lives.4 All patients with a thoracoplasty have a restrictive ventilatory defect,5 6 to which many factors contribute. Lung volumes are reduced by collapse of functioning lung tissue at the time of operation and lung compliance is reduced by residual pulmonary fibrosis. Scoliosis, which is inevitable after unilateral thoracoplasty,' 7 reduces chest wall compliance. In some patients the skeletal deformity results in paradoxical chest wall movement, which interferes with the expansion of both lungs.'8 In others pleural thickening limits expansion of the underlying lung, and we have found that its extent is related to Paco2.'9 Inspiratory muscle function is impaired by the effect of resection of individual muscles and by the mechanical disadvantage at which those remaining must work because of the skeletal deformity.
Chronic airflow obstruction leads to hyperinflation, which may produce a beneficial fall in airflow resistance.20 This is offset, however, by the increase in work associated with breathing at high lung volumes. When airflow obstruction is superimposed on the restrictive ventilatory defect of patients with a thoracoplasty, this increase in work will be greater than usual because of the decreased respiratory compliance and impaired inspiratory muscle function. Respiratory compliance2' and respiratory muscle power22 decline with age, so that as these patients grow older their respiratory reserve will decrease and some will develop chronic asymptomatic respiratory failure. In all these patients a critical level may be reached at which a minor insult or small increase in airflow obstruction could precipitate life
